The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Other Investors | Alive

About Bioabsorbable Therapeutics

Bioabsorbable Therapeutics, founded in 2004 is acquired by Xenogenics. It develops absorbable stents to treat vascular disease. The company utilizes novel, proprietary anti-inflammatory polymers to create fully bioabsorbable coatings and stents. It is based in Menlo Park, California.

Bioabsorbable Therapeutics Headquarter Location

959 Hamilton Avenue

Menlo Park, California, 94025,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • Where is Bioabsorbable Therapeutics's headquarters?

    Bioabsorbable Therapeutics's headquarters is located at 959 Hamilton Avenue, Menlo Park.

  • What is Bioabsorbable Therapeutics's latest funding round?

    Bioabsorbable Therapeutics's latest funding round is Other Investors.

  • Who are the investors of Bioabsorbable Therapeutics?

    Investors of Bioabsorbable Therapeutics include Synergy Partners International.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.